Concepedia

Cecilia L. Moore

CL

15

Publications

465

Citations

13

H-Index

1999

Active since

Affiliations

UNSW Sydney(Current)

Hôpital Saint-Louis

The Alfred Hospital

University College London

Joint Clinical Research Centre

Cecilia L. Moore is an author at UNSW Sydney specializing in medicine, hiv, and epidemiology.

ORCID

Top concepts

Publications per year

1999–2022

15

Publications

15

Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis

Mark Boyd, Cecilia L. Moore, Jean‐Michel Molina et al. · The Lancet HIV · 2015 · 79 citations · Full text

, , +7

Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial

Pauline Bollen, Cecilia L. Moore, Hilda Mujuru et al. · The Lancet HIV · 2020 · 46 citations · Full text

Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection

Janaki Amin, Mark Boyd, Nagalingeswaran Kumarasamy et al. · PLoS ONE · 2015 · 43 citations · Full text

Mental health and wellbeing coordinators in primary schools to support student mental health: protocol for a quasi-experimental cluster study

Simone Darling, Georgia Dawson, Jon Quach et al. · BMC Public Health · 2021 · 43 citations · Full text

Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels

William J. Hey-Cunningham, John M. Murray, Ven Natarajan et al. · AIDS · 2015 · 41 citations · Full text

Rows per page

1–5 of 15